Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The study objective is to quantify the effectiveness of ivermectin (subcutaneous/oral IVM) in the presence or absence of zinc (Zn) for clinical and radiological improvement in coronavirus disease 2019 (COVID-19) patients with moderate severity. TRIAL DESIGN: This quadruple-blinded, place...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashraf, Shoaib, Ashraf, Sohaib, Farooq, Iqra, Ashraf, Sidra, Ashraf, Moneeb, Imran, Muhammad Ahmad, Kalsoom, Larab, Akmal, Rutaba, Ghufran, Muhammad, Rafique, Sundas, Akram, Muhammad Kiwan, Habib, Zaigham, Siddiqui, Uzma Nasim, Ahmad, Ammara, Arshad, Shahroze, Virk, Muhammad Abdul Rehman, Gul, Mehak, Awais, Abeer bin, Hassan, Muhammad, Sherazi, Syed Sami Hussain, Safdar, Zartasha, Munir, Isra, Khalid, Hamna, Munir, Khalid, Majeed, Nighat, Alahmadi, Yaser Masuod, Humayun, Ayesha, Saboor, Qazi Abdul, Ahmad, Ali, Ashraf, Muhammad, Izhar, Mateen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419386/
https://www.ncbi.nlm.nih.gov/pubmed/34488858
http://dx.doi.org/10.1186/s13063-021-05487-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419386/
https://www.ncbi.nlm.nih.gov/pubmed/34488858
http://dx.doi.org/10.1186/s13063-021-05487-z

Ejemplares similares